4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0001482981-25-000144
President & CEO sold 25,000 shares at $22.75 ($568,750)
- President & CEO acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cloonan Michael President & CEO | 2025-08-20 | Option exercise 10b5-1 | +25,000 | $6.11 | $152,750 | 572,343 | D: show line 1 in the form |
| Cloonan Michael President & CEO | 2025-08-20 | Sale 10b5-1 | −25,000 | $22.75 | $568,750 | 547,343 | D: show line 2 in the form |
| Open-market sales · 25,000 sh · avg $22.75 · $568,750 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cloonan Michael President & CEO | 2025-08-20 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −25,000 | 228,142 | D: show line 3 in the form |
Loading xslF345X05/edgardoc.xml…